Related references
Note: Only part of the references are listed.Clinical and pathological analysis of giant cell tumor of bone with denosumab treatment and local recurrence
Kenta Hayashida et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2022)
Imaging of Spinal Bone Tumors: Principles and Practice
Shinji Tsukamoto et al.
CURRENT MEDICAL IMAGING (2022)
Role of denosumab before resection and reconstruction in giant cell tumors of bone: a single-centered retrospective cohort study
Badaruddin Sahito et al.
EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY (2022)
Fluid-fluid Levels in Musculoskeletal Tumor Imaging
Shinji Tsukamoto et al.
CURRENT MEDICAL IMAGING (2021)
Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study
Khodamorad Jamshidi et al.
INTERNATIONAL ORTHOPAEDICS (2021)
The impact of curettage technique on local control in giant cell tumour of bone
Gennady N. Machak et al.
INTERNATIONAL ORTHOPAEDICS (2021)
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Emanuela Palmerini et al.
BMC CANCER (2021)
Pulmonary metastasis of giant cell tumour: a retrospective study of three hundred and ten cases
Jun Wang et al.
INTERNATIONAL ORTHOPAEDICS (2021)
The role of Denosumab in joint preservation for patients with giant cell tumour of bone
D. L. Perrin et al.
BONE & JOINT JOURNAL (2021)
Malignancy in giant cell tumor of bone in the extremities
Weifeng Liu et al.
JOURNAL OF BONE ONCOLOGY (2021)
Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab
Andrew Chandler et al.
BMC MUSCULOSKELETAL DISORDERS (2021)
Giant cell tumors of the sacrum: is non-operative treatment effective?
Ajay Puri et al.
EUROPEAN SPINE JOURNAL (2021)
Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal
Stefano Boriani et al.
EUROPEAN SPINE JOURNAL (2020)
Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?
Andrea Sambri et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2020)
Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology
Mathilde Treffel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
Suraj Hindiskere et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2020)
Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy
C. Y. Lim et al.
BONE & JOINT JOURNAL (2020)
Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review
Alessandra Raimondi et al.
ESMO OPEN (2020)
Denosumab for Bone Giant Cell Tumor of the Distal Radius
Shinji Tsukamoto et al.
ORTHOPEDICS (2020)
Pre-operative prognostic nutritional index was associated with recurrence after surgery in giant cell tumor of bone patients
Shoulei Liang et al.
JOURNAL OF BONE ONCOLOGY (2020)
Risk factors for the local recurrence of giant cell tumours of the sacrum treated with nerve-sparing surgery
Y. Zhao et al.
BONE & JOINT JOURNAL (2020)
Outcome of lung metastases due to bone giant cell tumor initially managed with observation
Shinji Tsukamoto et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2020)
In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid
Isao Shibuya et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Bone combined cement grafting in giant cell tumor around the knee reduces mechanical failure
Wangsiyuan Teng et al.
INTERNATIONAL ORTHOPAEDICS (2019)
Denosumab does not decrease the risk of lung metastases from bone giant cell tumour
Shinji Tsukamoto et al.
INTERNATIONAL ORTHOPAEDICS (2019)
Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation
Shinji Tsukamoto et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities
Zhenhao Chen et al.
BMC CANCER (2019)
Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
Astrid Lipplaa et al.
ONCOLOGIST (2019)
Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases
HaiJun Tang et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Bisphosphonate-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Tumor of Bone A 1 to 12-Year Follow-up Study
David D. Greenberg et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2019)
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature
Emanuela Palmerini et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610
Hiroshi Urakawa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Development and proposal of a scoring system for giant cell tumour of the bone around the knee
Deng-xing Lun et al.
INTERNATIONAL ORTHOPAEDICS (2018)
Can Aortic Balloon Occlusion Reduce Blood Loss During Resection of Sacral Tumors That Extend Into the Lower Lumber Spine?
Yidan Zhang et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2018)
Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience
Manish G. Agarwal et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2018)
Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
Guido Scoccianti et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2018)
Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone
Hidetaka Yamamoto et al.
HUMAN PATHOLOGY (2018)
Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage
Costantino Errani et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2018)
Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine A Case Report
Gin Way Law et al.
SPINE (2018)
Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine
Noriaki Yokogawa et al.
EUROPEAN SPINE JOURNAL (2018)
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Jacob Engellau et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab
Yongkun Yang et al.
MEDICINE (2018)
Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture
M. R. Medellin et al.
BONE & JOINT JOURNAL (2018)
Malignant Sarcomatous Transformation of Benign Giant Cell Tumor of Bone after Treatment with Denosumab Therapy: A Literature Review of Reported Cases
Sadiq I. Alaqaili et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis
Boris Itkin et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications
Joseph Benevenia et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2017)
One-step reconstruction with a 3D-printed, custom-made prosthesis after total en bloc sacrectomy: a technical note
Ran Wei et al.
EUROPEAN SPINE JOURNAL (2017)
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E. Palmerini et al.
EUROPEAN JOURNAL OF CANCER (2017)
Giant cell tumour of bone in the denosumab era
Lizz van der Heijden et al.
EUROPEAN JOURNAL OF CANCER (2017)
Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites
Costantino Errani et al.
European Journal of Orthopaedic Surgery and Traumatology (2017)
Pulmonary metastasis from giant cell tumor of bone: clinical outcome prior to the introduction of molecular target therapy
Munehisa Kito et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab
Shinji Tsukamoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Long-term administration of bisphosphonate to reduce local recurrence of sacral giant cell tumor after nerve-sparing surgery
Wei Xu et al.
JOURNAL OF NEUROSURGERY-SPINE (2017)
Surveillance for lung metastasis from giant cell tumor of bone
Mamer Rosario et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Development and validation of a prognostic index to predict pulmonary metastasis of giant cell tumor of bone
Bo Wang et al.
ONCOTARGET (2017)
Selective Arterial Embolization for the Treatment of Sacral and Pelvic Giant Cell Tumor: A Systematic Review
Shao-hui He et al.
ORTHOPAEDIC SURGERY (2017)
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone
Fernanda Amary et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
THE ROLE OF DENOSUMAB IN THE MODERN TREATMENT OF GIANT CELL TUMOR OF BONE
Patrick Thornley et al.
JBJS REVIEWS (2017)
Clinical characteristics and risk factors analysis of lung metastasis from benign giant cell tumor of bone
Yongkun Yang et al.
JOURNAL OF BONE ONCOLOGY (2017)
Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone
Frank Traub et al.
EUROPEAN JOURNAL OF CANCER (2016)
Proposed Scoring System for Evaluating Neurologic Deficit after Sacral Resection: Functional Outcomes of 170 Consecutive Patients
Lin Huang et al.
SPINE (2016)
Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases
Arnaud Dubory et al.
SPINE (2016)
Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
Fengxia Chen et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma
Arjen H. G. Cleven et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone
Piotr Rutkowski et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab
Luis A. Aponte-Tinao et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone
Carol P. Y. Lau et al.
CONNECTIVE TISSUE RESEARCH (2015)
Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review
Yifei Ma et al.
EUROPEAN SPINE JOURNAL (2015)
Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage
Kun-Hui Chen et al.
EUROPEAN SPINE JOURNAL (2015)
Risk Factors for Pulmonary Metastases from Giant Cell Tumor of Bone
Chung Ming Chan et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2015)
Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone? A META-ANALYSIS
A. A. Salunke et al.
BONE & JOINT JOURNAL (2015)
Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab
Cory Julian Broehm et al.
CASE REPORTS IN MEDICINE (2015)
Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone
Francois Gouin et al.
EUROPEAN JOURNAL OF CANCER (2014)
Preservation of the contralateral sacral nerves during hemisacrectomy for sacral malignancies
Dasen Li et al.
EUROPEAN SPINE JOURNAL (2014)
A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab
Isabella W. Y. Mak et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)
Radiotherapy in the Management of Giant Cell Tumor of Bone
Wenyin Shi et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Factors Affecting Prognosis of Patients with Giant Cell Tumors of the Mobile Spine: Retrospective Analysis of 102 Patients in a Single Center
Wei Xu et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
Mark C. Genovese et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Giant Cell Tumor With Pathologic Fracture: Should We Curette or Resect?
Lizz van der Heijden et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2013)
Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone
Carol P. Y. Lau et al.
CONNECTIVE TISSUE RESEARCH (2013)
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten et al.
LANCET (2013)
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2013)
Clinical outcomes of giant cell tumor of bone treated with bone cement filling and internal fixation, and oral bisphosphonates
Xiuchun Yu et al.
ONCOLOGY LETTERS (2013)
Intralesional Excision versus Wide Resection for Giant Cell Tumor Involving the Acetabulum: Which is Better?
Wei Guo et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2012)
Giant Cell Tumor of the Mobile Spine A Review of 49 Cases
Stefano Boriani et al.
SPINE (2012)
Surgical strategy for the management of sacral giant cell tumors: a 32-case series
Guodong Li et al.
SPINE JOURNAL (2012)
A short-term in vivo model for giant cell tumor of bone
Maurice Balke et al.
BMC CANCER (2011)
Surgical classification of different types of en bloc resection for primary malignant sacral tumors
Dasen Li et al.
EUROPEAN SPINE JOURNAL (2011)
Primary Malignant Giant-Cell Tumor of Bone Has High Survival Rate
Stepan V. Domovitov et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone
Maurice Balke et al.
BMC CANCER (2010)
Giant cell tumor of the extremity: A review of 349 cases from a single institution
Costantino Errani et al.
CANCER TREATMENT REVIEWS (2010)
Giant cell tumour of the sacrum: a suggested algorithm for treatment
Rajkumar Thangaraj et al.
EUROPEAN SPINE JOURNAL (2010)
Giant cell tumor of the sacrum treated with selective arterial embolization
Hitoshi Onishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
THE MEGAVOLTAGE RADIATION THERAPY IN TREATMENT OF PATIENTS WITH ADVANCED OR DIFFICULT GIANT CELL TUMORS OF BONE
Wlodzimierz Ruka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Cytotoxic Effect of Zoledronic Acid-Loaded Bone Cement on Giant Cell Tumor, Multiple Myeloma, and Renal Cell Carcinoma Cell Lines
Pawel Zwolak et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2010)
Safety of denosumab in giant-cell tumour of bone
David Thomas et al.
LANCET ONCOLOGY (2010)
Treatment and outcome of giant cell tumors of the pelvis 20 cases followed for 1 to 11 years
Maurice Balke et al.
ACTA ORTHOPAEDICA (2009)
Risk Factors for Blood Loss During Sacral Tumor Resection
Xiaodong Tang et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Treatment options for recurrent giant cell tumors of bone
Maurice Balke et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Outcome of Conservative Surgery for Giant Cell Tumor of the Sacrum
Wei Guo et al.
SPINE (2009)
Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India
R. Gupta et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2008)
Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case-control study
Lung Fung Tse et al.
BONE (2008)
Giant cell tumor of the cervical spine - A series of 22 cases and outcomes
Ma Junming et al.
SPINE (2008)
Histologically verified lung metastases in benign giant cell tumours - 14 cases from a single institution
M. Dominkus et al.
INTERNATIONAL ORTHOPAEDICS (2006)
Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis
SS Chang et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone
YY Cheng et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
Giant cell tumor of the pelvis and sacrum - 17 cases and analysis of the literature
RE Leggon et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Tumors of the pelvis:: complications after reconstruction
A Hillmann et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2003)
Radiotherapy in the management of giant cell tumor of bone
JJ Caudell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization
PP Lin et al.
CANCER (2002)
Treatment of giant cell tumor of the distal radius
CY Cheng et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2001)
Share Paper
